These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 14117937)
1. [CONTRIBUTION TO THE STUDY OF ANGIOHEMOPHILIA]. GARBIN S Haematologica; 1963; 48():557-64. PubMed ID: 14117937 [No Abstract] [Full Text] [Related]
2. [GENEALOGIC AND CLINICAL STUDY OF A CASE OF HEMOPHILIA A WITH LENGTHENING OF THE BLEEDING TIME (ANGIOHEMOPHILIA A)]. CAMPI N; DEGREGORI ME Haematol Lat; 1964; 7():111-24. PubMed ID: 14256155 [No Abstract] [Full Text] [Related]
3. [CONSIDERATIONS OF THE DELIVERY AND PUERPERIUM OF A SUBJECT AFFECTED BY ANGIOHEMOPHILIA B]. MARZETTI L Quad Clin Ostet Ginecol; 1963 Oct; 18():683-9. PubMed ID: 14103067 [No Abstract] [Full Text] [Related]
8. Von Willebrand's disease in two families. Case reports with a contribution to the management of chronic intestinal hemorrhages. Salomon H; Tatarski I Isr J Med Sci; 1965 Jul; 1(4):866-9. PubMed ID: 5295184 [No Abstract] [Full Text] [Related]
9. [Test of generation of hematic thromboplastin in stage I. II. Results in some coagulation diseases]. CIOFFI LA; LAVITRANO R Boll Soc Ital Biol Sper; 1961 Dec; 37():1304-6. PubMed ID: 13879572 [No Abstract] [Full Text] [Related]
10. Clotting defect in hemophilia; deficiency in a plasma factor required for thromboplastin liberation from platelets. BRINKHOUS KM Fed Proc; 1947; 6(1):389. PubMed ID: 20343817 [No Abstract] [Full Text] [Related]
11. [The factor VIII complex: hemophilia A and von Willebrand disease]. Tobelem G; Rothschild C Sem Hop; 1982 Sep; 58(35):2032-6. PubMed ID: 6293093 [TBL] [Abstract][Full Text] [Related]
13. The coagulation activity of incomplete thromboplastins and bridge anticoagulant. PUDLAK P; DEIMLOVA E; STARA I Br J Haematol; 1959 Oct; 5():413-20. PubMed ID: 14435243 [No Abstract] [Full Text] [Related]
14. The influence of hydergine on the coagulation time in hemophilia. SIMONOVIC I Acta Haematol; 1955 Aug; 14(2):96-9. PubMed ID: 13258141 [No Abstract] [Full Text] [Related]
15. [The consumption of antihemophilic globulin and the development of thromboplastin accelerator power in the adsorbed plasma-recalcified serum mixture. The problem of the responsible serum substrate]. MAYER G; MAYER S; WAITZ R Rev Fr Etud Clin Biol; 1961 Nov; 6():924-8. PubMed ID: 14471688 [No Abstract] [Full Text] [Related]
16. VON WILLEBRAND'S DISEASE. Br Med J; 1964 Oct; 2(5415):963. PubMed ID: 14185681 [No Abstract] [Full Text] [Related]
17. [Effects of incubation on the anthemophilic globulin of adsorbed plasma and of adsorbed plasma-serum mixture. Absence of true consumption of the anthemophilic globulin and of development of a thromboplastin-accelerator power]. MAYER G; MAYER S C R Seances Soc Biol Fil; 1961; 155():653-6. PubMed ID: 14471691 [No Abstract] [Full Text] [Related]
19. [HAGEMAN FACTOR DEFICIENCY]. VERRASTRO T; COSTA MF; JAMRA M Rev Hosp Clin Fac Med Sao Paulo; 1963; 18():511-6. PubMed ID: 14119075 [No Abstract] [Full Text] [Related]
20. On demonstration of the haemophilic conductor, especially by determination of the coagulation time. SJØLIN KE Acta Pathol Microbiol Scand; 1954; 35(6):512-22. PubMed ID: 13228064 [No Abstract] [Full Text] [Related] [Next] [New Search]